JACC Specialty Journals

JACC: CardioOncology - JACC: CardioOncology - February 2025 Issue Summary

JACC: CardioOncology - SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics

Commentary by Dr. Ali Javaheri

JACC: CardioOncology - The Association of Malignancy with Stroke and Bleeding in Atrial Fibrillation: A Population-Based Cohort Study

Commentary by Dr. Lorenzo Gervaso

JACC: CardioOncology - Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients: Results from the Vienna CAT-BLED Study

Commentary by Dr. Vivek Narayan

JACC: CardioOncology - Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline- Based Chemotherapy

Commentary by Dr. Giselle Melendez

JACC: CardioOncology - Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

Commentary by Dr. Mina Sedrak

JACC: CardioOncology - Effects of Systemic Anticancer Treatment on Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis

Commentary by Dr. Erin Howden

Revisiting ICD Therapy for Primary Prevention in Patients With Heart Failure and Reduced Ejection Fraction

Dr. Valentin Fuster discusses the February 2025 issue of JACC, which focuses on advancements in heart failure research. The discussion covers five key sections: heart failure with preserved ejection fraction, hypertrophic cardiomyopathy, cardiac amyloidosis, standardization of kidney function, and ICD therapy for primary prevention in heart failure patients. Experts explore emerging therapies, diagnostic thresholds, and the potential impact of blood pressure and genetics on patient outcomes, und...

JACC: Advances - Climate Cardiology and the Impact of Wildfires on Cardiovascular Health

In this episode of JACC: Advances Pulse, moderator Dr Anju Bhardwaj discusses the emerging field of environmental cardiology with Dr. Sadeer Al Kindi and Dr Jamal Rana. They focus on climate cardiology and the impact of wildfires on cardiovascular health, pathways for building a career in this area, and the future of the field.

JACC: Asia - February 2025 Issue Summary

Audio Summary of the February 2025 Issue by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - Electrocardiographic Characteristics and Ablation Outcomes Associated With Para-Hisian Ventricular Arrhythmias

Commentary by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - Extended Period Outcomes of Posterior Box Isolation in 4 Randomized Atrial Fibrillation Catheter Ablation Trials

Commentary by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - Protruding and Ulcerated Aortic Atheromas as Predictors of Periprocedural Ischemic Stroke Post-Transcatheter Aortic Valve Replacement

Commentary by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - Extremely Small 20-mm Versus Standard-Size Balloon-Expandable Transcatheter Heart Valves: Propensity-Matched Analysis From the OCEAN-TAVI Registry

Commentary by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - OUFR Versus FFR for Functional Assessment of Coronary Artery Stenosis in Patients With Unstable Angina

Commentary by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - New Frontiers in Antegrade Wiring From the Asia Pacific Chronic Total Occlusion Club

Commentary by Dr. Jian'an Wang

JACC: Asia - Brief Introduction - Effect of Renal Impairment on Clinical Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair

Commentary by Dr. Jian'an Wang

JACC: Cardiovascular Interventions - Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial Program

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Gregg W. Stone, MD, FACC, discuss a recently published manuscript reporting the early and late outcomes of the Absorb bioresorbable vascular scaffold, the final report from the ABSORB clinical trial program.

JACC: Cardiovascular Interventions - Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Clinical Outcomes

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Thomas Pilgrim, MD, MSc, discuss a recently published manuscript reporting the incidence, predictors, and clinical outcomes hemodynamic valve deterioration after transcatheter aortic valve replacement.

JACC: Cardiovascular Interventions - Coronary Sinus Reducer Improves Angina, Quality of Life, and Coronary Flow Reserve in Microvascular Dysfunction

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Amir Lerman, MD, discuss the phase II study examining coronary sinus reducer for treatment of microvascular dysfunction.

JACC: Clinical Electrophysiology - Cardioverter-defibrillator implantation as a risk factor for motor vehicle crash

Ratika Parkash, MD, Deputy Editor of JACC: Clinical Electrophysiology discusses a recently published original research paper on cardioverter-defibrillator implantation as a risk factor for motor vehicle crashes.

JACC: CardioOncology Pulse - Cardiovascular Considerations After Cancer Therapy: Gaps in Evidence and JACC: CardioOncology Expert Panel Recommendations

Anne Blaes, MD, and Nicholas Wilcox, MD, MHS discuss JACC: CardioOncology Expert Panel Recommendations for cardiovascular care and surveillance after cancer therapy, including available evidence, practical recommendations, and key evidence gaps.

JACC: Advances - The Relationship Between Quantitative Ischemia, Early Revascularization, and Major Adverse Cardiovascular Events: A Multicenter Study

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on the Relationship Between Quantitative Ischemia, Early Revascularization, and Major Adverse Cardiovascular Events in a Multicenter Study.

JACC: Advances - Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa.

JACC: Advances - Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Incident Heart Failure Risk

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Incident Heart Failure Risk.

JACC: Advances - Transatlantic Telerobotic Coronary Angiography: A Pre-clinical Feasibility Study

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Transatlantic Telerobotic Coronary Angiography: A Pre-clinical Feasibility Study.

JACC: Advances - Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk Score

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk Score.

JACC: Advances - Propensity Score Analysis of Possible Medication Effects on Outcomes in Patients With Systemic Right Ventricles

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Propensity Score Analysis of Possible Medication Effects on Outcomes in Patients With Systemic Right Ventricles.

JACC: Advances - Interplay Between Residential Nature Exposure and Walkability and Their Association with Cardiovascular Health

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on the Interplay Between Residential Nature Exposure and Walkability and Their Association with Cardiovascular Health.

JACC: Advances - Hepatic Biomarker Abnormalities in the Cardiac Intensive Care Unit: Proposed Criteria for Cardiohepatic Syndrome

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Hepatic Biomarker Abnormalities in the Cardiac Intensive Care Unit: Proposed Criteria for Cardiohepatic Syndrome.